Answers are grounded in this paper and cite their sources.
Cohort study estimates government spending on pediatric drugs, highlighting issues with trials and approval.
This cohort study estimates Medicare Part D, Medicaid, and Medicare Part B spending on pediatric drugs approved by the US Food and Drug Administration from 2015 to 2021.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: